Abstract
BackgroundThe study aimed to investigate the meaning patients assign to two measures of quality of life: the Schedule for Evaluation of Individual Quality of Life Direct Weighting (SEIQoL-DW) and the SEIQoL-DW Disease Related (DR) version, in a clinical oncology setting. Even though the use of quality of life assessments has increased during the past decades, uncertainty regarding how to choose the most suitable measure remains. SEIQoL-DW versions assesses the individual’s perception of his or her present quality of life by allowing the individual to nominate the domains to be evaluated followed by a weighting procedure resulting in qualitative (domains) as well as quantitative outcomes (index score).MethodsThe study applied a cross-sectional design with a qualitative approach and collected data from a purposeful sample of 40 patients with gastrointestinal cancer. Patients were asked to complete two measures, SEIQoL-DW and the SEIQoL-DR, to assess quality of life. This included nomination of the areas in life considered most important and rating of these areas; after completion patients participated in cognitive interviews around their selections of areas. Interviews were audiotaped and transcribed verbatim which was followed by analysis using a phenomenographic approach.ResultsThe analyses of nominated areas of the two measures resulted in 11 domains reflecting what patients perceived had greatest impact on their quality of life. Analysis of the cognitive interviews resulted in 16 thematic categories explaining the nominated domains. How patients reflected around their quality of life appeared to differ by version (DW vs. DR). The DW version more often related to positive aspects in life while the DR version more often related to negative changes in life due to having cancer.ConclusionsThe two SEIQoL versions tap into different concepts; health-related quality of life, addressing losses and problems related to having cancer and, quality of life, more associated with aspects perceived as positive in life. The SEIQoL-DR and the SEIQoL-DW are recommended in clinical practice to take both negative and positive aspects into account and acting on the problems of greatest importance to the patient.
Highlights
The study aimed to investigate the meaning patients assign to two measures of quality of life: the Schedule for Evaluation of Individual Quality of Life Direct Weighting (SEIQoL-DW) and the SEIQoL-DW Disease Related (DR) version, in a clinical oncology setting
The results indicate that the SEIQOL-DR version taps into healthrelated quality of life (HRQOL) while the SEIQOL-DW version taps into QoL which is in line with results concerning standardized measures [28]
There is a qualitative variation in individuals’ thoughts and reasons for nominating several of the most important domains, when filling in the SEIQoL-DW compared to the SEIQoL-DR
Summary
The study aimed to investigate the meaning patients assign to two measures of quality of life: the Schedule for Evaluation of Individual Quality of Life Direct Weighting (SEIQoL-DW) and the SEIQoL-DW Disease Related (DR) version, in a clinical oncology setting. There are several existing PROMs assessing healthrelated quality of life (HRQOL) or disease symptoms in various patient populations Many of these measures are based on a generalized, nomothetic approach opting for group comparisons [8]. These type of measures have been criticised for their pre-set domains, enhancing the risk of missing domains essential for the individual’s QoL or including domains of less importance [8]. In contrast to this approach, individualized measures have been developed to capture the concept of QoL from an idiographic view, i.e., taking into account the uniqueness of the human experience [9,10]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have